A mathematical model of tumor-immune interactions

DOI10.1016/j.jtbi.2011.10.027zbMath1397.92358OpenAlexW2052208722WikidataQ51505011 ScholiaQ51505011MaRDI QIDQ1787000

Mark Robertson-Tessi, Alain Goriely, Ardith W. El-Kareh

Publication date: 26 September 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2011.10.027

zbMATH Keywords

tumor growth immunosuppression regulatory T cells TGF-\(\beta\)IL-10

Mathematics Subject Classification ID

Medical applications (general) (92C50) Cell biology (92C37)

Related Items

Comparative study for optimal control nonlinear variable-order fractional tumor model, The impact of distributed time delay in a tumor-immune interaction system, Interlocked feedback loops balance the adaptive immune response, A cancer treatment based on synergy between anti-angiogenic and immune cell therapies, A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy, A mathematical model for pancreatic cancer growth and treatments, Dynamic aspects of tumour–immune system interaction under a periodic immunotherapy, Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies, The influence of time delay in a chaotic cancer model, Analysis of noise-induced phenomena in the nonlinear tumor-immune system, Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment, Mathematical modelling of cancer stem cell-targeted immunotherapy, Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions, Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors, An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol, A TUMOR-IMMUNE MODEL WITH MIXED IMMUNOTHERAPY AND CHEMOTHERAPY: QUALITATIVE ANALYSIS AND OPTIMAL CONTROl, A tumor-Immune interaction model with the effect of impulse therapy, Computational modeling to determine the effect of phenotypic heterogeneity in tumors on the collective tumor-immune interactions, Mathematical and numerical modelling of interference of immune cells in the tumour environment, Optimal control of inhibiting tumor, new approach to sufficient \(\varepsilon\)-optimality and numerical computation, Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer, Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study, IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer, Control of tumor growth modeled by system of PDE, numerical analysis of optimality conditions, Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment, A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies, Global dynamics of a breast cancer competition model, A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS, Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma, A two-phenotype model of immune evasion by cancer cells, A comparison and catalog of intrinsic tumor growth models, MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS, Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy, A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications, Mathematical modeling of tumor-immune cell interactions, A mathematical model of cell-mediated immune response to tumor, Bifurcation analysis of a delayed mathematical model for tumor growth, Optimal control of variable-order fractional model for delay cancer treatments, Optimal treatment strategy for a tumor model under immune suppression, Identification of crucial parameters in a mathematical multiscale model of glioblastoma growth, Nonlinear dynamics in tumor-immune system interaction models with delays, Periodic and chaotic dynamics in a map-based model of tumor-immune interaction, A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy, A size and space structured model describing interactions of tumor cells with immune cells reveals cancer persistent equilibrium states in tumorigenesis, Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections, Complex dynamic behaviors of a tumor-immune system with two delays in tumor actions, Dynamics of breast cancer under different rates of chemoradiotherapy, Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives, An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data, Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy, A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies, Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response, Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative

Cites Work